Pricing Log in Create free account

CAMP4 Therapeutics Corporation (CAMP) vs InflaRx N.V. (IFRX)

CAMP4 Therapeutics Corporation and InflaRx N.V. are both Biotechnology companies. CAMP4 Therapeutics Corporation and InflaRx N.V. are of similar size ($216.5M and $212.2M). InflaRx N.V. has the higher net margin (0.00% vs −2,543.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, InflaRx N.V. leads on 9 and CAMP4 Therapeutics Corporation on 4.

Valuation

Metric CAMP IFRX Biotechnology median
P/E n/m n/m 8.50
P/S 43.56 5,075.70 9.71
P/B n/m 0.91 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.71 0.64
EV/Sales 22.90 (1,061.22) 9.21
Earnings yield (73.19%) (43.94%) (33.15%)
Free cash flow yield (15.62%) (17.60%) (25.50%)

Profitability

Metric CAMP IFRX Biotechnology median
Gross margin 100.00% (26,762.42%) 65.16%
Operating margin (1,254.22%) 0.00% 0.00%
Net margin (2,543.74%) 0.00% 0.00%
Free cash flow margin (680.36%) 0.00% 0.00%
Return on equity (545.85%) (38.71%) (56.36%)
Return on assets (148.23%) (32.75%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CAMP IFRX Biotechnology median
Revenue growth (TTM) — (83.39%) 6.02%
EPS growth (last fiscal year) 76.00% 9.41% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CAMP IFRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.70 8.22 4.72
Net debt to EBITDA 2.18 0.97 0.96

Dividend

Metric CAMP IFRX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CAMP IFRX Biotechnology median
Market cap 216.50m 212.21m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack